Anondita Medicare Limited (NSE:ANONDITA)
India
· Delayed Price · Currency is INR 720.00
+6.00 (0.84%)
At close: Mar 9, 2026
Anondita Medicare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
| Operating Revenue | 996.83 | 769.91 | 464.32 | 359.15 |
| Other Revenue | 0 | - | -0 | - |
| Revenue | 996.83 | 769.91 | 464.32 | 359.15 |
| Revenue Growth (YoY) | 177.55% | 65.81% | 29.28% | - |
| Cost of Revenue | 465.65 | 382.86 | 320.41 | 280.33 |
| Gross Profit | 531.18 | 387.05 | 143.92 | 78.82 |
| Selling, General & Admin | 102.67 | 94.04 | 18.69 | 15.46 |
| Other Operating Expenses | 72.95 | 35.26 | 33.89 | 26.52 |
| Operating Expenses | 185.35 | 138.57 | 59.14 | 48.24 |
| Operating Income | 345.84 | 248.48 | 84.78 | 30.59 |
| Interest Expense | -31.28 | -27.58 | -31.9 | -24.6 |
| Interest & Investment Income | 0.41 | 0.41 | 1.14 | 0.98 |
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0.06 | 0.33 |
| Other Non Operating Income (Expenses) | -1.69 | -1.69 | -2.58 | -2.62 |
| EBT Excluding Unusual Items | 313.27 | 219.62 | 51.5 | 4.68 |
| Gain (Loss) on Sale of Assets | -0.09 | -0.09 | - | - |
| Pretax Income | 313.18 | 219.53 | 51.53 | 4.68 |
| Income Tax Expense | 79.14 | 55.37 | 13.08 | 1.21 |
| Earnings From Continuing Operations | 234.05 | 164.17 | 38.45 | 3.47 |
| Minority Interest in Earnings | -4.52 | -6.23 | - | - |
| Net Income | 229.53 | 157.94 | 38.45 | 3.47 |
| Preferred Dividends & Other Adjustments | 6.23 | 6.23 | - | - |
| Net Income to Common | 223.3 | 151.71 | 38.45 | 3.47 |
| Net Income Growth | 6516.49% | 310.80% | 1008.30% | - |
| Shares Outstanding (Basic) | 14 | 11 | 13 | - |
| Shares Outstanding (Diluted) | 14 | 11 | 13 | - |
| Shares Change (YoY) | - | -15.35% | - | - |
| EPS (Basic) | 16.33 | 13.48 | 2.89 | - |
| EPS (Diluted) | 16.33 | 13.48 | 2.89 | - |
| EPS Growth | - | 366.15% | - | - |
| Free Cash Flow | -95.02 | -174.75 | 65.06 | -97.95 |
| Free Cash Flow Per Share | -6.95 | -15.53 | 4.89 | - |
| Gross Margin | 53.29% | 50.27% | 31.00% | 21.95% |
| Operating Margin | 34.69% | 32.27% | 18.26% | 8.52% |
| Profit Margin | 22.40% | 19.71% | 8.28% | 0.97% |
| Free Cash Flow Margin | -9.53% | -22.70% | 14.01% | -27.27% |
| EBITDA | 355.56 | 257.75 | 91.34 | 36.84 |
| EBITDA Margin | 35.67% | 33.48% | 19.67% | 10.26% |
| D&A For EBITDA | 9.73 | 9.27 | 6.57 | 6.26 |
| EBIT | 345.84 | 248.48 | 84.78 | 30.59 |
| EBIT Margin | 34.69% | 32.27% | 18.26% | 8.52% |
| Effective Tax Rate | 25.27% | 25.22% | 25.39% | 25.81% |
| Revenue as Reported | 1,001 | 771.3 | 465.55 | 361.4 |
| Advertising Expenses | - | 10.29 | 0.01 | 0.03 |
Source: S&P Capital IQ. Standard template. Financial Sources.